Simcere Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 2/6
Simcere Pharmaceutical Group is a dividend paying company with a current yield of 1.92% that is well covered by earnings. Next payment date is on 14th July, 2025 with an ex-dividend date of 18th June, 2025.
Key information
1.9%
Dividend yield
3.3%
Buyback Yield
| Total Shareholder Yield | 5.2% |
| Future Dividend Yield | 4.1% |
| Dividend Growth | 2.3% |
| Next dividend pay date | 14 Jul 25 |
| Ex dividend date | 18 Jun 25 |
| Dividend per share | n/a |
| Payout ratio | 55% |
Recent dividend and buyback updates
Recent updates
We Like Simcere Pharmaceutical Group's (HKG:2096) Earnings For More Than Just Statutory Profit
May 06
Simcere Pharmaceutical Group Limited's (HKG:2096) Price In Tune With Revenues
Mar 06Simcere Pharmaceutical Group Limited's (HKG:2096) P/S Still Appears To Be Reasonable
Nov 21Simcere Pharmaceutical Group Limited (HKG:2096) Not Lagging Market On Growth Or Pricing
Jul 29Why Simcere Pharmaceutical Group's (HKG:2096) Shaky Earnings Are Just The Beginning Of Its Problems
May 01Simcere Pharmaceutical Group Limited's (HKG:2096) Business And Shares Still Trailing The Market
Dec 29Need To Know: Analysts Just Made A Substantial Cut To Their Simcere Pharmaceutical Group Limited (HKG:2096) Estimates
Aug 28Are Investors Undervaluing Simcere Pharmaceutical Group Limited (HKG:2096) By 40%?
Jun 03Analysts Just Shaved Their Simcere Pharmaceutical Group Limited (HKG:2096) Forecasts Dramatically
Apr 06Estimating The Intrinsic Value Of Simcere Pharmaceutical Group Limited (HKG:2096)
Jan 10Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 2096 has been paying a dividend for less than 10 years.
Growing Dividend: 2096's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| Simcere Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2096) | 1.9% |
| Market Bottom 25% (HK) | 3.0% |
| Market Top 25% (HK) | 7.8% |
| Industry Average (Pharmaceuticals) | 2.8% |
| Analyst forecast (2096) (up to 3 years) | 4.1% |
Notable Dividend: 2096's dividend (1.92%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.95%).
High Dividend: 2096's dividend (1.92%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.8%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (54.8%), 2096's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (63%), 2096's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/06 20:29 |
| End of Day Share Price | 2025/05/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Simcere Pharmaceutical Group Limited is covered by 17 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shaojing Tong | BofA Global Research |
| Bo Yu | China International Capital Corporation Limited |
| Shitong Han | Citic Securities Co., Ltd. |